Evidence map›Paper›PMID 37753394›Full record

ArticleRSC advances2023

Dual activity of indolin-2-ones containing an arylidene motif: DNA and BSA interaction.

Syed Nasir Abbas Bukhari, Tariq G Alsahli, Hasan Ejaz, Naveed Ahmed, Waqas Ahmad, Mervat A Elsherif, Nasser H Alotaibi, Kashaf Junaid, Nenad Janković

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Syed Nasir Abbas BukhariDepartment of Pharmaceutical Chemistry, College of Pharmacy, Jouf University Sakaka Al Jouf 72388 Saudi Arabia sbukhari@ju.edu.sa.
Tariq G AlsahliDepartment of Pharmacology, College of Pharmacy, Jouf University Sakaka Al Jouf 72388 Saudi Arabia TGAlsahli@ju.edu.sa.
Hasan EjazDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University Sakaka Al Jouf 72388 Saudi Arabia hetariq@ju.edu.sa.
Naveed AhmedDepartment of Pharmaceutics, College of Pharmacy, Jouf University Sakaka Al Jouf 72388 Saudi Arabia nakahmad@ju.edu.sa.
Waqas AhmadDiscipline of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Universiti Sains Malaysia Gelugor 11800 Penang Malaysia waqas@usm.my.
Mervat A ElsherifChemistry Department, College of Science, Jouf University Sakaka Al Jouf 72388 Saudi Arabia maelsherif@ju.edu.sa.
Nasser H AlotaibiDepartment of Clinical Pharmacy, College of Pharmacy, Jouf University Sakaka 72388 Saudi Arabia nhalotaibi@ju.edu.sa.
Kashaf JunaidSchool of Biological and Behavioural Sciences, Queen Mary University of London London E1 4NS UK kashaf.junaid@qmul.ac.uk.
Nenad JankovićUniversity of Kragujevac, Institute for Information of Technologies Kragujevac, Department of Science Jovana Cvijića bb 34000 Kragujevac Serbia nenad.jankovic@kg.ac.rs.ORCID https://orcid.org/0000-0002-2295-9410

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Applying a multistep approach, novel indolin-2-ones (IND) that possess an arylidene motif have been synthesized. Eight compounds were chosen for different biological tests (antimicrobial and cytotoxicity). IND containing 2-thienyl (4h) fragment have been found to exhibit good antimicrobial activity against

Identifiers

PMID37753394
PMCPMC10518658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.